Heart failure & cardiomyopathies
Feasibility and safety of endomyocardial biopsy by lumenless pacing lead sheath–directed method during cardiac implantable electronic device implantation
Authors' conclusion
RV EMB by the innovative L-S-M is technically feasible and safe.
Study context
- Population
- Patients with an indication for a cardiovascular implantable electronic device (CIED) referred for endomyocardial biopsy (EMB)consecutive
- Participants
- 80 patients
- Exposure
- Right ventricular (RV) EMB by lead sheath method vs traditional bioptome method during CIED implantation
- Lead sheath method (L-S-M)n = 60
- Traditional bioptome method (T-B-M)n = 20reference
- Outcome
- Safety and feasibility (procedural details, success rate, complications)
Methodological detailsconsecutive patients
- Consecutive patients
Main finding
As reported in the abstract
Samples per patient
L-S-M
4.1
± 0.8
T-B-M
3.8
± 0.8
Observational data: associations, not effects.
Safety
Minor complications
Transient RBBB L-S-M 3
Transient AV block L-S-M 2
Regional minor device pocket hematoma L-S-M 2
Temporary pacing for transient AV block T-B-M 1
Chest discomfort T-B-M 1
Regional hematoma T-B-M 1
Minor complications
- No cardiac tamponade detected
Original publication
Feasibility and safety of endomyocardial biopsy by lumenless pacing lead sheath–directed method during cardiac implantable electronic device implantation. Heart Rhythm. Published 17 November 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →